Vasileios Lekakis

2.8k total citations · 1 hit paper
27 papers, 280 citations indexed

About

Vasileios Lekakis is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Vasileios Lekakis has authored 27 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Vasileios Lekakis's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (7 papers) and Nutrition and Health in Aging (3 papers). Vasileios Lekakis is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (7 papers) and Nutrition and Health in Aging (3 papers). Vasileios Lekakis collaborates with scholars based in Greece, United Kingdom and United States. Vasileios Lekakis's co-authors include George Papatheodoridis, Εvangelos Cholongitas, Theodoros Voulgaris, Jia‐Horng Kao, Pietro Lampertico, Henry Lik‐Yuen Chan, Norah A. Terrault, K. Rajender Reddy, Anna S. Lok and Thomas Berg and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Hepatology and Critical Care.

In The Last Decade

Vasileios Lekakis

22 papers receiving 277 citations

Hit Papers

Natural history of metabolic dysfunction-associated steat... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasileios Lekakis Greece 9 182 104 45 44 24 27 280
Érika Rabelo Forte de Siqueira Brazil 8 235 1.3× 144 1.4× 67 1.5× 81 1.8× 18 0.8× 12 357
М. V. Maevskaya Russia 7 142 0.8× 78 0.8× 23 0.5× 54 1.2× 26 1.1× 34 206
Agata Michalak Poland 12 128 0.7× 66 0.6× 47 1.0× 29 0.7× 24 1.0× 26 284
Ryuta Shigefuku Japan 10 167 0.9× 115 1.1× 50 1.1× 39 0.9× 53 2.2× 41 294
Cristina Muzîca Romania 9 263 1.4× 174 1.7× 58 1.3× 78 1.8× 12 0.5× 48 364
Θεόδωρος Ανδρουτσάκος Greece 10 239 1.3× 145 1.4× 61 1.4× 123 2.8× 20 0.8× 36 390
Tae Hun Kim South Korea 11 128 0.7× 75 0.7× 36 0.8× 26 0.6× 49 2.0× 28 296
Ji Dong Jia China 8 307 1.7× 155 1.5× 50 1.1× 101 2.3× 13 0.5× 15 370
Toru Setsu Japan 11 129 0.7× 108 1.0× 39 0.9× 27 0.6× 24 1.0× 35 315

Countries citing papers authored by Vasileios Lekakis

Since Specialization
Citations

This map shows the geographic impact of Vasileios Lekakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasileios Lekakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasileios Lekakis more than expected).

Fields of papers citing papers by Vasileios Lekakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasileios Lekakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasileios Lekakis. The network helps show where Vasileios Lekakis may publish in the future.

Co-authorship network of co-authors of Vasileios Lekakis

This figure shows the co-authorship network connecting the top 25 collaborators of Vasileios Lekakis. A scholar is included among the top collaborators of Vasileios Lekakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasileios Lekakis. Vasileios Lekakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lekakis, Vasileios, et al.. (2025). Association of Hormonal Status With Sarcopenia, Frailty and Outcome in Patients With Decompensated Cirrhosis. Liver International. 45(11). e70384–e70384. 1 indexed citations
3.
Karatzas, Pantelis, Panagiotis Kanellopoulos, Angeliki Papapanagiotou, et al.. (2025). The importance of vitamin D levels in patients with inflammatory bowel disease. Journal of Physiology and Biochemistry. 81(3). 729–739.
4.
Papadakos, Stavros P., Ioannis Katsaros, Vasileios Lekakis, et al.. (2024). The Impact of EndoVAC in Addressing Post-Esophagectomy Anastomotic Leak in Esophageal Cancer Management. Journal of Clinical Medicine. 13(23). 7113–7113. 1 indexed citations
6.
Lekakis, Vasileios, Florence Wong, Aikaterini Gkoufa, George Papatheodoridis, & Εvangelos Cholongitas. (2024). Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings. Alimentary Pharmacology & Therapeutics. 61(3). 420–432. 1 indexed citations
7.
Papadakos, Stavros P., Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.. (2024). Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications. Cancers. 16(8). 1533–1533. 6 indexed citations
8.
Karatzas, Pantelis, Panagiotis Kanellopoulos, Angeliki Papapanagiotou, et al.. (2024). The importance of growth differentiation factor 15 and interleukin 6 serum levels in inflammatory bowel diseases. Journal of Physiology and Biochemistry. 81(1). 111–122. 1 indexed citations
9.
Karagiannakis, Dimitrios S., Georgios Markakis, & Vasileios Lekakis. (2024). Evaluation of spleen stiffness by 2D shear wave elastography for ruling out high risk varices in patients with chronic advanced liver disease. A systematic review and meta-analysis. European Journal of Radiology. 175. 111475–111475. 6 indexed citations
10.
Papadakos, Stavros P., Vasileios Lekakis, Konstantinos Arvanitakis, et al.. (2024). Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights. International Journal of Molecular Sciences. 25(5). 2978–2978. 7 indexed citations
11.
Lekakis, Vasileios, Aikaterini Gkoufa, Jiannis Vlachogiannakos, George Papatheodoridis, & Εvangelos Cholongitas. (2024). Incidence and risk factors of acute kidney injury in cirrhosis: a systematic review and meta-analysis of 5,202,232 outpatients, inpatients, and ICU-admitted patients. Expert Review of Gastroenterology & Hepatology. 18(7). 377–388. 3 indexed citations
12.
Lekakis, Vasileios, et al.. (2024). Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis. Hepatology International. 18(2). 688–699. 10 indexed citations
13.
Arvanitakis, Konstantinos, Stavros P. Papadakos, Vasileios Lekakis, et al.. (2023). Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches. International Journal of Molecular Sciences. 24(19). 14704–14704. 10 indexed citations
14.
Papadakos, Stavros P., Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.. (2023). The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?. Cancers. 15(10). 2795–2795. 21 indexed citations
15.
Marantos, Theodoros, Evdoxia Kyriazopoulou, Vasileios Lekakis, Konstantinos Voumvourakis, & Sotirios Tsiodras. (2023). Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences. 456. 122852–122852. 3 indexed citations
16.
Gkoufa, Aikaterini, Vasileios Lekakis, George Papatheodoridis, & Εvangelos Cholongitas. (2023). Seroconversion following a booster dose of COVID-19 vaccine in liver transplant recipients. A systematic review and meta-analysis. Polskie Archiwum Medycyny Wewnętrznej. 133(9). 2 indexed citations
17.
Lempesis, Ioannis, Eleni Karlafti, Petros Papalexis, et al.. (2023). COVID-19 and liver injury in individuals with obesity. World Journal of Gastroenterology. 29(6). 908–916. 9 indexed citations
18.
Lekakis, Vasileios & George Papatheodoridis. (2023). Natural history of metabolic dysfunction-associated steatotic liver disease. European Journal of Internal Medicine. 122. 3–10. 78 indexed citations breakdown →
19.
Lekakis, Vasileios & Εvangelos Cholongitas. (2022). The impact of emricasan on chronic liver diseases: current data. Clinical Journal of Gastroenterology. 15(2). 271–285. 12 indexed citations
20.
Papatheodoridis, George, Vasileios Lekakis, Theodoros Voulgaris, et al.. (2022). Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion. Journal of Hepatology. 77(6). 1670–1689. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026